Zentalis Pharmaceuticals
ZNTL
#8235
Rank
ยฃ0.24 B
Marketcap
ยฃ3.39
Share price
4.16%
Change (1 day)
214.79%
Change (1 year)

Revenue for Zentalis Pharmaceuticals (ZNTL)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of ยฃ53.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Zentalis Pharmaceuticals from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A-100%
2024 ยฃ53.72 M
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
ยฃ0.43 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
ยฃ0.17 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA